These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

294 related articles for article (PubMed ID: 33891888)

  • 21. Adjuvant hormone therapy in locally advanced and localized prostate cancer: three EORTC trials.
    Bolla M; de Reijke TM; Zurlo A; Collette L
    Front Radiat Ther Oncol; 2002; 36():81-6. PubMed ID: 11842758
    [No Abstract]   [Full Text] [Related]  

  • 22. Putting evidence into practice: evidence-based interventions for hot flashes resulting from cancer therapies.
    Kaplan M; Mahon S; Cope D; Keating E; Hill S; Jacobson M
    Clin J Oncol Nurs; 2011 Apr; 15(2):149-57. PubMed ID: 21444282
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Therapeutic options for the management of hot flashes in breast cancer survivors: an evidence-based review.
    Bordeleau L; Pritchard K; Goodwin P; Loprinzi C
    Clin Ther; 2007 Feb; 29(2):230-41. PubMed ID: 17472816
    [TBL] [Abstract][Full Text] [Related]  

  • 24. LHRH agonists for adjuvant therapy of early breast cancer in premenopausal women.
    Sharma R; Hamilton A; Beith J
    Cochrane Database Syst Rev; 2008 Oct; (4):CD004562. PubMed ID: 18843661
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Assessment of quality of life in women undergoing hormonal therapy for breast cancer: validation of an endocrine symptom subscale for the FACT-B.
    Fallowfield LJ; Leaity SK; Howell A; Benson S; Cella D
    Breast Cancer Res Treat; 1999 May; 55(2):189-99. PubMed ID: 10481946
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Overview of long term care of breast cancer survivors.
    Brennan ME; Houssami N
    Maturitas; 2011 Jun; 69(2):106-12. PubMed ID: 21489727
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hot flashes and their management in breast cancer.
    Carpenter JS
    Semin Oncol Nurs; 2000 Aug; 16(3):214-25. PubMed ID: 10967794
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Management of aromatase inhibitor induced musculoskeletal symptoms in postmenopausal early Breast cancer: A systematic review and meta-analysis.
    Roberts K; Rickett K; Greer R; Woodward N
    Crit Rev Oncol Hematol; 2017 Mar; 111():66-80. PubMed ID: 28259297
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Symptom Map of Endocrine Therapy for Breast Cancer: A Scoping Review.
    Zhu Y; Cohen SM; Rosenzweig MQ; Bender CM
    Cancer Nurs; 2019; 42(5):E19-E30. PubMed ID: 30138143
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Adjuvant therapy for breast cancer.
    NIH Consens Statement; 2000 Nov 1-3; 17(4):1-35. PubMed ID: 11512506
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Breast cancer survivors and hot flashes: the search for nonhormonal treatments.
    Avis NE
    J Clin Oncol; 2008 Nov; 26(31):5008-10. PubMed ID: 18809600
    [No Abstract]   [Full Text] [Related]  

  • 32. Clinical management of adverse events in adjuvant therapy for hormone-responsive early breast cancer.
    Monnier A
    Ann Oncol; 2007 Sep; 18 Suppl 8():viii36-44. PubMed ID: 17890213
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Management of menopause in women with breast cancer.
    Vincent AJ
    Climacteric; 2015 Oct; 18(5):690-701. PubMed ID: 25536007
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The impact of symptom clusters on endocrine therapy adherence in patients with breast cancer.
    Agnew S; Crawford M; MacPherson I; Shiramizu V; Fleming L
    Breast; 2024 Jun; 75():103731. PubMed ID: 38599048
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Impact on quality of life of adjuvant therapy for breast cancer.
    Moore HC
    Curr Oncol Rep; 2007 Jan; 9(1):42-6. PubMed ID: 17164046
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Recognition and management of treatment-related side effects for breast cancer patients receiving adjuvant endocrine therapy.
    Cella D; Fallowfield LJ
    Breast Cancer Res Treat; 2008 Jan; 107(2):167-80. PubMed ID: 17876703
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Sequential hormonal therapy for metastatic breast cancer after adjuvant tamoxifen or anastrozole.
    Carlson RW; Henderson IC
    Breast Cancer Res Treat; 2003; 80 Suppl 1():S19-26; discussion S27-8. PubMed ID: 14535531
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Adjuvant endocrine therapy in women with oestrogen-receptor-positive breast cancer: how should the skeletal and vascular side effects be assessed and managed?
    Ramchand SK; Lim E; Grossmann M
    Clin Endocrinol (Oxf); 2016 Nov; 85(5):689-693. PubMed ID: 27497423
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Ear acupuncture for hot flushes--the perceptions of women with breast cancer.
    Walker G; de Valois B; Davies R; Young T; Maher J
    Complement Ther Clin Pract; 2007 Nov; 13(4):250-7. PubMed ID: 17950180
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Adjuvant endocrine therapy for the surgeon: options, side effects, and their management.
    Connor C; Attai D
    Ann Surg Oncol; 2013 Oct; 20(10):3188-93. PubMed ID: 23975307
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.